Blueprint Medicines (BPMC) is expected to update on the avapritinib Phase 2 PIONEER trial for indolent systematic mastocytosis on Monday. Morgan Stanley analyst… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3050444/-Before-the-Move-Watch-Blueprint-Medicines-into-Phase–trial-update)
previous post